SARS-CoV-2 promotes microglial synapse elimination in human brain organoids

Samudyata1, Ana O Oliveira1, Susmita Malwade1

  • 1Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.

Molecular Psychiatry
|October 5, 2022
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection triggers brain cell death and synapse loss. Microglia contribute to cognitive impairments in COVID-19 patients by eliminating synapses.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Neuropsychiatric issues are frequent in COVID-19 patients.
  • Mechanisms behind these neurological effects remain unclear.

Purpose of the Study:

  • Investigate SARS-CoV-2 effects on brain cells.
  • Elucidate the role of microglia in COVID-19-associated neurological deficits.

Main Methods:

  • Utilized a novel brain organoid model with developing microglia.
  • Performed single-cell transcriptomic profiling of microglia.
  • Analyzed neuronal cell death and synapse loss post-SARS-CoV-2 exposure.

Main Results:

  • SARS-CoV-2 infection caused neuronal cell death and loss of postsynaptic termini.
  • Microglial engulfment of synapses increased threefold.
  • SARS-CoV-2-exposed microglia showed upregulated interferon and migration/engulfment genes.
  • Microglial transcriptomic profiles resembled those in neurodegenerative disorders.

Conclusions:

  • SARS-CoV-2 disrupts brain circuit integrity through microglia-mediated synapse elimination.
  • This pathway may contribute to cognitive impairments observed in COVID-19 recovery.

Related Concept Videos